FDA approves U.S. study of Kips Bay Medical's surgical mesh

11/14/2012 | MassDevice.com (Boston)

The FDA has granted Kips Bay Medical investigational device exemption approval to test the use of its eSVS mesh in patients undergoing coronary artery bypass graft surgery. The conditional approval allows the company to add four U.S. clinical sites to an ongoing clinical trial of the device, which is used during CABG procedures to aid in keeping vein grafts open.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ